Product Overview
Wantai BioPharm has been deeply involved in the Chinese blood screening field for more than 30 years and has long focused on nucleic acid blood screening. To effectively ensure the safety of medical blood use and reduce the risk of virus transmission through blood, with quality as the core and combined with market feedback, the company has continuously innovated and grandly launched the third-generation highly sensitive nucleic acid Test for blood screening.
This Test has internationally leading detection sensitivity and can comprehensively cover various pathogen genotypes (including HIV-2 type), providing precise protection for nucleic acid detection in blood screening. It adopts the safe and efficient third-generation nucleic acid rotation extraction patented technology, combined with the innovative ready-to-use packaging design of Wantai. Not only does it greatly improve the detection efficiency, but also through the optimization of the operation process throughout, it builds a solid technical barrier for blood safety.
High Sensitivity
Safety
High Efficiency
Innovation
Core Features
Internationally Advanced Detection Sensitivity
HBV: 3IU/ml; HCV: 10 IU/ml; HIV-1: 40 IU/ml; HIV-2: 10 IU/ml.
Full Coverage of Pathogen Genotypes
HBV: A-H; HCV: 1-6; HIV-1: Group M, Group O, Group N; HIV-2.
The Third-generation Nucleic Acid Rotation Extraction Technology
It adopts the exclusive patented third-generation nucleic acid rotation extraction technology, which improves the efficiency and purity of nucleic acid extraction, avoids aerosol pollution, protects the integrity of the virus structure, and further ensures the accuracy of nucleic acid detection results.
Innovative "Ready-to-Use" Test Packaging
The innovative "ready-to-use" packaging design of the Chinese nucleic acid blood screening test of Wantai BioPharm allows the test to be directly loaded onto the machine after being split, without the need for manual tube transfer and liquid preparation. It is convenient and fast, and at the same time reduces the risk of human-source pollution.
Supporting Fully Automated Highly Sensitive Nucleic Acid Blood Screening Integrated Workstation
The workstation integrates sample loading, extraction, amplification, detection, and report analysis. It adopts an integrated software operating system, realizing the flexible combination of single-test and mixed-test modes. It monitors the quality throughout the test, customizes and generates reports, and truly achieves full automation from sample loading to result analysis without human intervention.
  • Full-process Automation
    It integrates sample loading, extraction, amplification, detection, and report analysis, achieving full-process automation from sample loading to result analysis without human intervention, significantly improving work efficiency and reducing contamination carried by personnel.
  • The Third-generation Nucleic Acid Rotation Extraction Technology
    It adopts the exclusive patented third-generation nucleic acid rotation extraction technology, which improves the efficiency and purity of nucleic acid extraction, avoids aerosol pollution, protects the integrity of the virus structure, and further ensures the accuracy of nucleic acid detection results.
  • Multiple Anti-pollution Designs
    The internal part of the instrument has multiple anti-pollution designs at different stages of sample mixing, extraction, and amplification, further ensuring the reliability of nucleic acid detection results.
  • Flexible Combination of Single-test and Mixed-test
    It supports the flexible combination of single-test and mixed-test modes, intelligently plans the detection process, improves the detection throughput, and optimizes the resource utilization efficiency.
  • Customized Personalized Reports
    It supports the customized generation of personalized reports. According to the needs of different institutions, it can customize the report format and content, provide detailed detection information and quality control data, which is convenient for result interpretation and data management.
  • Integrated Software System
    It adopts a highly integrated software operating system, with a user-friendly interface and simple operation. It integrates all detection links, provides intuitive monitoring and result analysis functions, and reduces human operation errors.
  • Full-process Quality Monitoring
    It conducts full-process quality monitoring of the test. There are strict quality control measures in each link from sample loading, nucleic acid extraction to amplification detection, ensuring the accuracy and reliability of detection results.
Application Areas
The fully automated ultra-sensitive nucleic acid blood screening integrated workstation is widely applied in nucleic acid testing of blood in various medical institutions, providing strong support for ensuring public health safety.
Blood Banks
It provides blood banks with an efficient and accurate solution for screening donors' blood, ensuring the safety of clinical blood use and reducing the risk of blood-borne infectious diseases.
Hospital Transfusion Departments
It reduces the risk of cross-infection within hospitals and occupational exposure of medical staff, detects virus-positive infected individuals at an early stage, further improves the transfusion safety of clinical patients, and reduces medical disputes and conflicts.
Biopharmaceutical Enterprises
To ensure the quality of blood products and prevent the use of plasma positive for blood-borne pathogens in the production of blood products, nucleic acid screening is carried out on the apheresis plasma population, ensuring the safe use of blood products from the source.
For more information :  wtexport@ystwt.com